Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Eur Radiol Retrieve available abstracts of 173 articles: HTML format

Single Articles

October 2025
1. NJOLSTAD TH, Jensen K, Andersen HK, Berstad AE, et al
   Deep learning reconstruction for detection of liver lesions at standard-dose and reduced-dose abdominal CT.
   Eur Radiol. 2025;35:6140-6149.
   PubMed     Abstract available
   
   
   
2. DIOGUARDI BURGIO M, Ronot M, Vilgrain V
   ESR Essentials: assessing the radiological response of liver metastases to systemic therapy-practice recommendations by the European Society of Gastrointestinal and Abdominal Radiology.
   Eur Radiol. 2025;35:6516-6526.
   PubMed     Abstract available
   
   
   
3. MATHUR A, Ozkaya E, Rosberger S, Sigel KM, et al
   Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease.
   Eur Radiol. 2025;35:6507-6515.
   PubMed     Abstract available
   
   
   September 2025
4. TAO Y, Song M, Zhang H, He H, et al
   Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis.
   Eur Radiol. 2025 Sep 12. doi: 10.1007/s00330-025-11994.
   PubMed     Abstract available
   
   
   
5. LUDEMANN WM, Kahn J, Pustelnik D, Hardt J, et al
   Correction: Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
   Eur Radiol. 2025 Sep 11. doi: 10.1007/s00330-025-11907.
   PubMed    
   
   
   
6. LEWIN M, Aldhaheri R, Beaufrere A, Desterke C, et al
   Imaging features of recently identified low-grade vascular neoplasia of the liver: hepatic small vessel neoplasm and anastomosing hemangioma.
   Eur Radiol. 2025 Sep 4. doi: 10.1007/s00330-025-11915.
   PubMed     Abstract available
   
   
   
7. MINAMIGUCHI K, Maki H, Haddad A, Cortes AC, et al
   Synthetic tumor extracellular volume as a predictive biomarker for colorectal liver metastasis patients prior to curative hepatectomy.
   Eur Radiol. 2025;35:5348-5359.
   PubMed     Abstract available
   
   
   August 2025
8. CHOI SJ, Kim HY, Lee SJ, Kim SY, et al
   Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS.
   Eur Radiol. 2025 Aug 22. doi: 10.1007/s00330-025-11938.
   PubMed     Abstract available
   
   
   
9. MA W, Huang X, Feng Z, Tan W, et al
   A novel multi-parameter MRI-based model for identification of high-risk metabolic dysfunction-associated steatohepatitis.
   Eur Radiol. 2025 Aug 21. doi: 10.1007/s00330-025-11944.
   PubMed     Abstract available
   
   
   
10. LIU Z, Chen H, Yang S, Zhang R, et al
    Preoperative prediction model of microvascular invasion in intrahepatic cholangiocarcinoma patients based on CT radiomics can assist clinical surgical decision-making: a multicenter study.
    Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11900.
    PubMed     Abstract available
    
    
    
11. CHE F, Li Q, Ren W, Tang H, et al
    3D fractal dimension analysis of CT imaging for microvascular invasion prediction in hepatocellular carcinoma.
    Eur Radiol. 2025 Aug 7. doi: 10.1007/s00330-025-11878.
    PubMed     Abstract available
    
    
    
12. LI Y, Chen Y, Wu Z, Shi Y, et al
    Noninvasive MRI imaging feature-based prediction of intratumoral tertiary lymphoid structure maturity in hepatocellular carcinoma: a multicenter retrospective study.
    Eur Radiol. 2025 Aug 6. doi: 10.1007/s00330-025-11902.
    PubMed     Abstract available
    
    
    
13. YUAN T, Zhong T, Song J
    Vascular penetration sign: dual-phase enhanced CT manifestations of atypical liver abscess caused by Klebsiella pneumoniae.
    Eur Radiol. 2025;35:4685-4691.
    PubMed     Abstract available
    
    
    
14. KIM SU, Hwang JA, Han S, Lee JH, et al
    Refining imaging criteria for mucinous cystic neoplasm of the liver: simplified diagnostic approach.
    Eur Radiol. 2025;35:4993-5003.
    PubMed     Abstract available
    
    
    July 2025
15. ZHANG G, Li M, Feng H, Ren Y, et al
    Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis.
    Eur Radiol. 2025 Jul 30. doi: 10.1007/s00330-025-11842.
    PubMed     Abstract available
    
    
    
16. CHOI JW, Suh M, Choi Y, Lee M, et al
    Yttrium-90 glass microsphere radioembolization as frontline treatment for hepatocellular carcinoma with localized portal vein invasion.
    Eur Radiol. 2025 Jul 26. doi: 10.1007/s00330-025-11882.
    PubMed     Abstract available
    
    
    
17. GWON DI, Kim GH, Chu HH, Kim J, et al
    Long-term outcomes of plug-assisted retrograde transvenous obliteration (PARTO) for refractory hepatic encephalopathy.
    Eur Radiol. 2025 Jul 16. doi: 10.1007/s00330-025-11831.
    PubMed     Abstract available
    
    
    
18. BANE O, Geahchan A, Stocker D, Pavuluri S, et al
    Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe portal hypertension.
    Eur Radiol. 2025 Jul 15. doi: 10.1007/s00330-025-11799.
    PubMed     Abstract available
    
    
    
19. HE X, Shi F, Cui Y, Liu J, et al
    Differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma with MRI and tumor markers: a multi-center study.
    Eur Radiol. 2025 Jul 2. doi: 10.1007/s00330-025-11780.
    PubMed     Abstract available
    
    
    
20. ALI R, Li H, Zhang H, Pan W, et al
    Multi-site, multi-vendor development and validation of a deep learning model for liver stiffness prediction using abdominal biparametric MRI.
    Eur Radiol. 2025;35:4362-4373.
    PubMed     Abstract available
    
    
    June 2025
21. HAMADOUCHE M, Vilgrain V, Hobeika C, Castera L, et al
    Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation study.
    Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11774.
    PubMed     Abstract available
    
    
    
22. CHEN H, Zhu J, Zhou J, Yin Z, et al
    MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response.
    Eur Radiol. 2025 Jun 12. doi: 10.1007/s00330-025-11726.
    PubMed     Abstract available
    
    
    
23. GRIGORIADIS A, Bergquist A, Kartalis N
    Shading light in the black box of hepatobiliary imaging.
    Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11740.
    PubMed    
    
    
    
24. PARK R, Kim DH, Choi SH, Kim J, et al
    Preoperative scoring system for predicting microvascular invasion in intrahepatic cholangiocarcinoma using gadoxetate-enhanced MRI.
    Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11722.
    PubMed     Abstract available
    
    
    
25. ERLEY J, Naimi L, Molwitz I, Aydemir DG, et al
    Novel insights into cardiac structure, function, perfusion, and tissue characteristics in liver cirrhosis: a magnetic resonance analysis.
    Eur Radiol. 2025 Jun 5. doi: 10.1007/s00330-025-11710.
    PubMed     Abstract available
    
    
    
26. JIANG H, Li B, Zheng T, Qin Y, et al
    MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC
    Eur Radiol. 2025;35:3223-3237.
    PubMed     Abstract available
    
    
    
27. JENSEN CT, Wong VK, Likhari GS, Daoud TE, et al
    Dual-energy CT for differentiation of hypodense liver lesions in pancreatic adenocarcinoma.
    Eur Radiol. 2025;35:3538-3546.
    PubMed     Abstract available
    
    
    
28. EL HOMSI M, Bou Ayache J, Fernandes MC, Horvat N, et al
    Comparison of abbreviated and complete MRI protocols for treatment response assessment of colorectal liver metastases.
    Eur Radiol. 2025;35:3450-3459.
    PubMed     Abstract available
    
    
    
29. IMAJO K, Saigusa Y, Kobayashi T, Nagai K, et al
    Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.
    Eur Radiol. 2025;35:3599-3609.
    PubMed     Abstract available
    
    
    
30. JING HH, Hao D, Liu XJ, Cui MJ, et al
    Development and validation of a radiopathomics model for predicting liver metastases of colorectal cancer.
    Eur Radiol. 2025;35:3409-3417.
    PubMed     Abstract available
    
    
    
31. LI J, Li Y, Chen YY, Wang XY, et al
    Predicting post-hepatectomy liver failure with T1 mapping-based whole-liver histogram analysis on gadoxetic acid-enhanced MRI: comparison with the indocyanine green clearance test and albumin-bilirubin scoring system.
    Eur Radiol. 2025;35:3587-3598.
    PubMed     Abstract available
    
    
    
32. KOBAYASHI T, Kozaka K, Matsubara T, Yokka A, et al
    Super delayed phase imaging in gadoxetic acid-enhanced MRI: investigating factors contributing to improved liver contrast.
    Eur Radiol. 2025;35:3195-3205.
    PubMed     Abstract available
    
    
    
33. TIE J, Yuan X, Liu Z, Gou X, et al
    Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results.
    Eur Radiol. 2025;35:3256-3261.
    PubMed     Abstract available
    
    
    May 2025
34. OCAL O, Zech CJ, Bali MA, Pasquier D, et al
    Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR.
    Eur Radiol. 2025 May 23. doi: 10.1007/s00330-025-11699.
    PubMed     Abstract available
    
    
    
35. WEI H, Jiang H, Yoo J, Kim JH, et al
    Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma.
    Eur Radiol. 2025 May 17. doi: 10.1007/s00330-025-11659.
    PubMed     Abstract available
    
    
    
36. ELBANNA KY, Khalili K, AlMoharb M, Goel A, et al
    Qualitative and quantitative assessment of gadoxetic acid MRI in distinguishing atypical focal nodular hyperplasia from hepatocellular adenoma subtypes.
    Eur Radiol. 2025 May 14. doi: 10.1007/s00330-025-11679.
    PubMed     Abstract available
    
    
    
37. VERDAN S, Torri GB, Marcos VN, Moreira MHS, et al
    Ultrasound-derived fat fraction for diagnosing hepatic steatosis: a systematic review and meta-analysis.
    Eur Radiol. 2025 May 9. doi: 10.1007/s00330-025-11652.
    PubMed     Abstract available
    
    
    
38. WU Y, Ye Z, Yang T, Yao S, et al
    Preoperative prediction of early recurrence in hepatocellular carcinoma using simultaneous multislice diffusion kurtosis imaging.
    Eur Radiol. 2025 May 6. doi: 10.1007/s00330-025-11633.
    PubMed     Abstract available
    
    
    
39. RUAN J, He Y, Li Q, Song M, et al
    CT feature of irregular extensive ulceration as a predictor of liver metastasis in gastric gastrointestinal stromal tumours.
    Eur Radiol. 2025;35:2759-2768.
    PubMed     Abstract available
    
    
    
40. ALVES VPV, Mouzaki M, Xanthakos SA, Zhang B, et al
    Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography.
    Eur Radiol. 2025;35:2474-2486.
    PubMed     Abstract available
    
    
    April 2025
41. MU M, Cao Y, Chen Z, Fu X, et al
    Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis.
    Eur Radiol. 2025 Apr 17. doi: 10.1007/s00330-025-11571.
    PubMed     Abstract available
    
    
    
42. SONG W, Xu Y, Zhou J, Yu J, et al
    Predicting postresection outcomes in solitary small hepatocellular carcinoma via pretreatment MR imaging features: subgroup analysis according to alpha-fetoprotein expression.
    Eur Radiol. 2025 Apr 11. doi: 10.1007/s00330-025-11558.
    PubMed     Abstract available
    
    
    
43. ZHANG Y, Zhang Z, Yin X, Xu A, et al
    Hepatic arterial infusion chemotherapy versus transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
    Eur Radiol. 2025 Apr 11. doi: 10.1007/s00330-025-11557.
    PubMed     Abstract available
    
    
    
44. CANNELLA R, Agnello F, Porrello G, Spinello AU, et al
    Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2025;35:2339-2350.
    PubMed     Abstract available
    
    
    
45. REITHMEIER B, Laun FB, Fuhres T, Uder M, et al
    Relevance of lesion size in navigator-triggered and free-breathing diffusion-weighted liver MRI.
    Eur Radiol. 2025;35:2106-2115.
    PubMed     Abstract available
    
    
    
46. ZHANG Y, Huang C, Meng F, Hu X, et al
    Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis.
    Eur Radiol. 2025;35:2330-2338.
    PubMed     Abstract available
    
    
    March 2025
47. GWON DI, Chu HH, Kim GH, Kim J, et al
    Conventional transcatheter arterial chemoembolization with gelatin spheres for hepatocellular carcinoma: comparison with nonspherical gelatin sponge particles.
    Eur Radiol. 2025 Mar 27. doi: 10.1007/s00330-025-11527.
    PubMed     Abstract available
    
    
    
48. YANG HK, Lee S, Lee MY, Kim MJ, et al
    Effectiveness of noncontrast-abbreviated magnetic resonance imaging in a real-world hepatocellular carcinoma surveillance.
    Eur Radiol. 2025 Mar 20. doi: 10.1007/s00330-025-11517.
    PubMed     Abstract available
    
    
    
49. NAGAYAMA Y, Hokamura M, Taguchi N, Yokota Y, et al
    Liver function estimation using multiphase hepatic CT: diagnostic performance of iodine-uptake and volumetric parameters.
    Eur Radiol. 2025 Mar 13. doi: 10.1007/s00330-025-11497.
    PubMed     Abstract available
    
    
    
50. SABORIDO B, Darnell A, Forner A, Garcia-Criado A, et al
    Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients.
    Eur Radiol. 2025 Mar 7. doi: 10.1007/s00330-025-11495.
    PubMed     Abstract available
    
    
    
51. OTA T, Onishi H, Fukui H, Tsuboyama T, et al
    Prediction models for differentiating benign from malignant liver lesions based on multiparametric dual-energy non-contrast CT.
    Eur Radiol. 2025;35:1361-1377.
    PubMed     Abstract available
    
    
    February 2025
52. ZHANG L, Xiao Y, Dong M, Li M, et al
    Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and Cytokeratin-19 in hepatocellular carcinoma.
    Eur Radiol. 2025 Feb 18. doi: 10.1007/s00330-025-11375.
    PubMed     Abstract available
    
    
    
53. HEO S, Jeong B, Lee SS, Kim M, et al
    CT-based detection of clinically significant portal hypertension predicts post-hepatectomy outcomes in hepatocellular carcinoma.
    Eur Radiol. 2025 Feb 14. doi: 10.1007/s00330-025-11411.
    PubMed     Abstract available
    
    
    
54. KIM DH, Choi SH, Koo B, Choi SJ, et al
    Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma.
    Eur Radiol. 2025 Feb 10. doi: 10.1007/s00330-025-11418.
    PubMed     Abstract available
    
    
    
55. LAIMER G, Verdonschot KHM, Kopf L, van der Lei S, et al
    Multicenter and inter-software evaluation of ablative margins after thermal ablation of colorectal liver metastases.
    Eur Radiol. 2025;35:1046-1056.
    PubMed     Abstract available
    
    
    January 2025
56. XU H, Wang H, Yu SZ, Li XM, et al
    Prognostic and diagnostic value of [(18)F]FDG, (11)C-acetate, and [(68)Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-025-11352.
    PubMed     Abstract available
    
    
    
57. ZHAO Y, Becce F, Balmer R, do Amaral RH, et al
    Prognostic value of CT-based skeletal muscle and adipose tissue mass and quality parameters in patients with liver metastases and intrahepatic cholangiocarcinoma undergoing Yttrium-90 radioembolization.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-025-11349.
    PubMed     Abstract available
    
    
    
58. ZHOU T, Han X, Xiao C, Lei X, et al
    Diagnostic accuracy of preoperative MRI in assessing macrotrabecular-massive subtype of hepatocellular carcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-024-11344.
    PubMed     Abstract available
    
    
    
59. MALTHIERY C, Hossu G, Ayav A, Laurent V, et al
    Characterization of hepatocellular carcinoma with CT with deep learning reconstruction compared with iterative reconstruction and 3-Tesla MRI.
    Eur Radiol. 2025 Jan 8. doi: 10.1007/s00330-024-11314.
    PubMed     Abstract available
    
    
    
60. WEI H, Zheng T, Zhang X, Zheng C, et al
    Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resection.
    Eur Radiol. 2025;35:127-139.
    PubMed     Abstract available
    
    
    December 2024
61. ZHAO H, Zhang X, Huang B, Shi X, et al
    Application of machine learning methods for predicting esophageal variceal bleeding in patients with cirrhosis.
    Eur Radiol. 2024 Dec 21. doi: 10.1007/s00330-024-11311.
    PubMed     Abstract available
    
    
    
62. DUPUIS M, Dupont A, Pizza S, Vilgrain V, et al
    Prognostic value of early response in predicting survival in hepatocellular carcinoma patients treated with selective internal radiation therapy.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11253.
    PubMed     Abstract available
    
    
    
63. COLLETTINI F, Andrasina T, Reimer P, Schima W, et al
    Degradable starch microspheres transarterial chemoembolization (DSM-TACE) in patients with unresectable hepatocellular carcinoma: results from the Prospective Multicenter Observational HepaStar Trial.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11272.
    PubMed     Abstract available
    
    
    
64. SHENG R, Zheng B, Zhang Y, Sun W, et al
    MRI-based microvascular invasion prediction in mass-forming intrahepatic cholangiocarcinoma: survival and therapeutic benefit.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11296.
    PubMed     Abstract available
    
    
    
65. ZHANG W, Li N, Li J, Zhao Y, et al
    Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluation.
    Eur Radiol. 2024 Dec 12. doi: 10.1007/s00330-024-11247.
    PubMed     Abstract available
    
    
    
66. LI Y, Li X, Xiao X, Cheng J, et al
    A novel hybrid model for predicting tertiary lymphoid structures and targeted immunotherapy outcomes in hepatocellular carcinoma: a multicenter retrospective study.
    Eur Radiol. 2024 Dec 10. doi: 10.1007/s00330-024-11255.
    PubMed     Abstract available
    
    
    November 2024
67. HU Q, Li G, Zhang D, Jiang Y, et al
    Assessment of four-dimensional flow MRI for prediction of varices risk in cirrhotic patients.
    Eur Radiol. 2024 Nov 27. doi: 10.1007/s00330-024-11222.
    PubMed     Abstract available
    
    
    
68. ZHANG L, Mai X, Li B, Li H, et al
    Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-related steatohepatitic hepatocellular carcinoma.
    Eur Radiol. 2024 Nov 22. doi: 10.1007/s00330-024-11151.
    PubMed     Abstract available
    
    
    
69. PATEL RK, Tripathy T, Chandel K, Marri UK, et al
    Left-sided portal hypertension: what an interventional radiologist can offer?
    Eur Radiol. 2024 Nov 19. doi: 10.1007/s00330-024-11196.
    PubMed     Abstract available
    
    
    
70. WANG Y, Mao S, Huang R, Li S, et al
    MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up.
    Eur Radiol. 2024 Nov 12. doi: 10.1007/s00330-024-11185.
    PubMed     Abstract available
    
    
    
71. JEONG B, Heo S, Lee SS, Kim SO, et al
    Predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma: nomograms based on deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2024 Nov 12. doi: 10.1007/s00330-024-11173.
    PubMed     Abstract available
    
    
    
72. LEE S, Kim YY, Shin J, Shin H, et al
    Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis.
    Eur Radiol. 2024;34:7025-7040.
    PubMed     Abstract available
    
    
    
73. EDIN C, Ekstedt M, Karlsson M, Wegmann B, et al
    Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis.
    Eur Radiol. 2024;34:7492-7502.
    PubMed     Abstract available
    
    
    October 2024
74. QI R, Lu L, He T, Zhang L, et al
    Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study.
    Eur Radiol. 2024 Oct 16. doi: 10.1007/s00330-024-11119.
    PubMed     Abstract available
    
    
    
75. YAN Y, Yang L
    Reply to Letter to the Editor: "Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease".
    Eur Radiol. 2024;34:6955-6956.
    PubMed    
    
    
    
76. JIANG C, Feng Q
    Letter to the Editor: "Liver stiffness by two?dimensional shear wave elastography for screening high?risk varices in patients with compensated advanced chronic liver disease".
    Eur Radiol. 2024;34:6953-6954.
    PubMed    
    
    
    
77. WEI H, Yoon JH, Jeon SK, Choi JW, et al
    Enhancing gadoxetic acid-enhanced liver MRI: a synergistic approach with deep learning CAIPIRINHA-VIBE and optimized fat suppression techniques.
    Eur Radiol. 2024;34:6712-6725.
    PubMed     Abstract available
    
    
    September 2024
78. NAKAZAWA Y, Okada M, Tago K, Kuwabara N, et al
    MR elastography vs a combination of common non-invasive tests for estimation of severe liver fibrosis in patients with hepatobiliary tumors.
    Eur Radiol. 2024 Sep 30. doi: 10.1007/s00330-024-11086.
    PubMed     Abstract available
    
    
    
79. GU K, Min JH
    Reply to Letter to the Editor: "Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection" from Xiaoping Yu, MD; Huaping Liu, MD.
    Eur Radiol. 2024 Sep 11. doi: 10.1007/s00330-024-11068.
    PubMed    
    
    
    
80. YU X, Liu H
    Letter to the Editor: "Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection".
    Eur Radiol. 2024 Sep 11. doi: 10.1007/s00330-024-11067.
    PubMed    
    
    
    
81. AZIZI N, Naghibi H, Shakiba M, Morsali M, et al
    Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis.
    Eur Radiol. 2024 Sep 10. doi: 10.1007/s00330-024-11001.
    PubMed     Abstract available
    
    
    
82. MARRA P, Franchi-Abella S, Hernandez JA, Ronot M, et al
    Percutaneous recanalization of non-cirrhotic extrahepatic portal vein obstruction in children: technical considerations in a preliminary cohort.
    Eur Radiol. 2024 Sep 6. doi: 10.1007/s00330-024-11040.
    PubMed     Abstract available
    
    
    
83. WANG Y, Qu Y, Yang C, Wu Y, et al
    MRI-based prediction of the need for wide resection margins in patients with single hepatocellular carcinoma.
    Eur Radiol. 2024 Sep 5. doi: 10.1007/s00330-024-11043.
    PubMed     Abstract available
    
    
    
84. LIN YM, Paolucci I, Albuquerque Marques Silva J, O'Connor CS, et al
    Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study.
    Eur Radiol. 2024;34:5541-5550.
    PubMed     Abstract available
    
    
    
85. SCHMIDT VF, Ocal O, Walther V, Fabritius MP, et al
    Clinical benefits of MRI-guided freehand biopsy of small focal liver lesions in comparison to CT guidance.
    Eur Radiol. 2024;34:5507-5516.
    PubMed     Abstract available
    
    
    August 2024
86. BARR RG, Ferraioli G
    Letter to the Editor: "Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound".
    Eur Radiol. 2024 Aug 7. doi: 10.1007/s00330-024-10916.
    PubMed    
    
    
    
87. BYENFELDT M
    Reply to Letter to Editor: "Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound".
    Eur Radiol. 2024 Aug 7. doi: 10.1007/s00330-024-10917.
    PubMed    
    
    
    
88. SCIALPI M, Evangelisti A, Shehu K, Comite P, et al
    Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma.
    Eur Radiol. 2024 Aug 2. doi: 10.1007/s00330-024-10925.
    PubMed    
    
    
    
89. CANNELLA R, Zins M, Brancatelli G
    Reply to "Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma".
    Eur Radiol. 2024 Aug 2. doi: 10.1007/s00330-024-10927.
    PubMed    
    
    
    
90. POETTER-LANG S, Ambros R, Messner A, Kristic A, et al
    Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.
    Eur Radiol. 2024;34:5215-5227.
    PubMed     Abstract available
    
    
    
91. GROSS M, Huber S, Arora S, Ze'evi T, et al
    Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomics.
    Eur Radiol. 2024;34:5056-5065.
    PubMed     Abstract available
    
    
    July 2024
92. MEYBLUM L, Faron M, Deschamps F, Kobe A, et al
    Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy.
    Eur Radiol. 2024 Jul 30. doi: 10.1007/s00330-024-10887.
    PubMed     Abstract available
    
    
    
93. KIM DH, Min EJ, Kim B, Choi JY, et al
    RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab.
    Eur Radiol. 2024 Jul 30. doi: 10.1007/s00330-024-10986.
    PubMed     Abstract available
    
    
    
94. XU W, Zhang H, Zhang R, Zhong X, et al
    Deep learning model based on contrast-enhanced ultrasound for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.
    Eur Radiol. 2024 Jul 27. doi: 10.1007/s00330-024-10985.
    PubMed     Abstract available
    
    
    
95. SOBIREY R, Matuschewski N, Gross M, Lin M, et al
    Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.
    Eur Radiol. 2024 Jul 20. doi: 10.1007/s00330-024-10955.
    PubMed     Abstract available
    
    
    
96. PAN J, Huang H, Zhang S, Zhu Y, et al
    Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.
    Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10944.
    PubMed     Abstract available
    
    
    
97. WANG F, Zhang Q, Yan K, Jing X, et al
    3D-CEUS/MRI-CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation.
    Eur Radiol. 2024 Jul 11. doi: 10.1007/s00330-024-10915.
    PubMed     Abstract available
    
    
    
98. RONOT M
    Illuminating the shades of hyper- to isointense lesions in hepatobiliary phase imaging.
    Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10894.
    PubMed    
    
    
    
99. GU K, Jeong WK, Cha DI, Hwang JA, et al
    Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary complications after ABO-incompatible liver transplantation.
    Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10914.
    PubMed     Abstract available
    
    
    
100. ZOU X, Liu L, Tan F, Tang H, et al
     Non-contrast-enhanced MR angiography of left gastric vein in patients with gastroesophageal varices: morphology and blood supply analysis.
     Eur Radiol. 2024;34:4686-4696.
     PubMed     Abstract available
     
     
     
101. PEREIRA PL, Siemou P, Rempp HJ, Hoffmann R, et al
     CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
     Eur Radiol. 2024;34:4663-4671.
     PubMed     Abstract available
     
     
     
102. CAO J, Shon A, Yoon L, Kamaya A, et al
     Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease.
     Eur Radiol. 2024 Jul 1. doi: 10.1007/s00330-024-10846.
     PubMed     Abstract available
     
     
     June 2024
103. FURUMAYA A, Willemssen FEJA, Miclea RL, Haring MPD, et al
     Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI.
     Eur Radiol. 2024 Jun 20. doi: 10.1007/s00330-024-10829.
     PubMed     Abstract available
     
     
     
104. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
     Correction: Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
     Eur Radiol. 2024 Jun 18. doi: 10.1007/s00330-024-10745.
     PubMed    
     
     
     
105. PICKHARDT PJ, Blake GM, Moeller A, Garrett JW, et al
     Post-contrast CT liver attenuation alone is superior to the liver-spleen difference for identifying moderate hepatic steatosis.
     Eur Radiol. 2024 Jun 4. doi: 10.1007/s00330-024-10816.
     PubMed     Abstract available
     
     
     
106. VAN DER REIJD DJ, Guerendel C, Staal FCR, Busard MP, et al
     Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
     Eur Radiol. 2024;34:3635-3643.
     PubMed     Abstract available
     
     
     
107. DUMAN S, Kuru D, Gumussoy M, Kiremitci S, et al
     A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
     Eur Radiol. 2024;34:3882-3888.
     PubMed     Abstract available
     
     
     May 2024
108. GU K, Min JH, Lee JH, Shin J, et al
     Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection.
     Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10780.
     PubMed     Abstract available
     
     
     
109. CHEN J, Wu Z, Zhang Z, Chen Y, et al
     Apparent diffusion coefficient and tissue stiffness are associated with different tumor microenvironment features of hepatocellular carcinoma.
     Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10743.
     PubMed     Abstract available
     
     
     
110. VOUCHE M
     Large-scale data from real-life practice of percutaneous liver thermal ablation from an international registry: unconditionally trustful Atlas or colossus with feet of clay?
     Eur Radiol. 2024;34:3320-3321.
     PubMed    
     
     
     
111. ZENSEN S, Bucker A, Meetschen M, Haubold J, et al
     Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
     Eur Radiol. 2024;34:3322-3330.
     PubMed     Abstract available
     
     
     
112. MENDIRATTA-LALA M, Aslam A, Bai HX, Chapiro J, et al
     Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
     Eur Radiol. 2024;34:3284-3297.
     PubMed     Abstract available
     
     
     
113. LEWIN M
     Can HCC postresection survival be predicted with prognostic MRI features?
     Eur Radiol. 2024;34:3160-3162.
     PubMed    
     
     
     April 2024
114. RATA M, De Paepe KN, Orton MR, Castagnoli F, et al
     Evaluation of simultaneous multi-slice acquisition with advanced processing for free-breathing diffusion-weighted imaging in patients with liver metastasis.
     Eur Radiol. 2024;34:2457-2467.
     PubMed     Abstract available
     
     
     
115. CARUSO D, De Santis D, Del Gaudio A, Guido G, et al
     Low-dose liver CT: image quality and diagnostic accuracy of deep learning image reconstruction algorithm.
     Eur Radiol. 2024;34:2384-2393.
     PubMed     Abstract available
     
     
     
116. NAKAZAWA Y, Okada M, Hyodo T, Tago K, et al
     Comparison between CT volumetry, technetium(99m) galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.
     Eur Radiol. 2024;34:2212-2222.
     PubMed     Abstract available
     
     
     March 2024
117. GROSS M, Haider SP, Ze'evi T, Huber S, et al
     Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning.
     Eur Radiol. 2024 Mar 27. doi: 10.1007/s00330-024-10624.
     PubMed     Abstract available
     
     
     
118. KIM TH, Woo S, Lee DH, Do RK, et al
     MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
     Eur Radiol. 2024 Mar 20. doi: 10.1007/s00330-024-10671.
     PubMed     Abstract available
     
     
     
119. BOUATTOUR M, Vilgrain V, Sepulveda A
     ESR Bridges: imaging and treatment of hepatocellular carcinoma-a multidisciplinary view.
     Eur Radiol. 2024 Mar 15. doi: 10.1007/s00330-023-10579.
     PubMed    
     
     
     
120. BYENFELDT M, Kihlberg J, Nasr P, Gronlund C, et al
     Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
     Eur Radiol. 2024 Mar 8. doi: 10.1007/s00330-024-10655.
     PubMed     Abstract available
     
     
     
121. ZHANG A, Meng X, Yao Y, Zhou X, et al
     Head to head comparison of (68)Ga-DOTA-FAPI-04 vs (18)F-FDG PET/CT in the evaluation of primary extrapulmonary tumors in the chest.
     Eur Radiol. 2024;34:1960-1970.
     PubMed     Abstract available
     
     
     February 2024
122. YOO J, Joo I, Jeon SK, Park J, et al
     Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
     Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10660.
     PubMed     Abstract available
     
     
     
123. CANNELLA R, Zins M, Brancatelli G
     ESR Essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR.
     Eur Radiol. 2024 Feb 21. doi: 10.1007/s00330-024-10606.
     PubMed     Abstract available
     
     
     
124. VARIN E, Beunon P, N'Kontchou G, Petit A, et al
     Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
     Eur Radiol. 2024 Feb 9. doi: 10.1007/s00330-024-10617.
     PubMed     Abstract available
     
     
     
125. KIM GH, Kim JH, Shim JH, Kim SY, et al
     Chemoembolization versus radiofrequency ablation for single small (
     Eur Radiol. 2024 Feb 8. doi: 10.1007/s00330-024-10634.
     PubMed     Abstract available
     
     
     
126. ZHANG Y, Hu X, Chang J, Li W, et al
     A new method to estimate the histological stage of primary biliary cholangitis.
     Eur Radiol. 2024;34:770-779.
     PubMed     Abstract available
     
     
     
127. ZHANG Y, Fan X, Song B, Liu Y, et al
     Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.
     Eur Radiol. 2024;34:1268-1279.
     PubMed     Abstract available
     
     
     January 2024
128. LIU W, Wei R, Chen J, Li Y, et al
     Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.
     Eur Radiol. 2024 Jan 30. doi: 10.1007/s00330-024-10581.
     PubMed     Abstract available
     
     
     
129. XU Y, Yang Y, Ouyang J, Zhou Y, et al
     Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
     Eur Radiol. 2024 Jan 29. doi: 10.1007/s00330-023-10575.
     PubMed    
     
     
     
130. AUER TA
     Diffusion-weighted imaging for the detection of liver metastases in the preoperative evaluation of pancreatic cancer - are we really at the end of the road?
     Eur Radiol. 2024;34:103-105.
     PubMed    
     
     
     
131. ALTMAYER S, Armelin LM, Pereira JS, Carvalho LV, et al
     MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis.
     Eur Radiol. 2024;34:106-114.
     PubMed     Abstract available
     
     
     
132. QIN S, Chen Y, Wang Y, Li F, et al
     Contrast-enhanced ultrasound with microbubbles containing sulfur hexafluoride and perfluorobutane with Kupffer phase for the detection of colorectal liver metastases.
     Eur Radiol. 2024;34:622-631.
     PubMed     Abstract available
     
     
     
133. CUI E
     Reducing radiation dose in routine CT scans: an AI-driven approach with deep learning-based dual-energy CT reconstruction.
     Eur Radiol. 2024;34:26-27.
     PubMed    
     
     
     
134. LYU P, Li Z, Chen Y, Wang H, et al
     Deep learning reconstruction CT for liver metastases: low-dose dual-energy vs standard-dose single-energy.
     Eur Radiol. 2024;34:28-38.
     PubMed     Abstract available
     
     
     
135. MIN JH, Lee MW, Rhim H, Han S, et al
     LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
     Eur Radiol. 2024;34:525-537.
     PubMed     Abstract available
     
     
     December 2023
136. TAOULI B, Ba-Ssalamah A, Chapiro J, Chhatwal J, et al
     Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
     Eur Radiol. 2023;33:9152-9166.
     PubMed     Abstract available
     
     
     
137. JOSKOWICZ L, Szeskin A, Rochman S, Dodi A, et al
     Follow-up of liver metastases: a comparison of deep learning and RECIST 1.1.
     Eur Radiol. 2023;33:9320-9327.
     PubMed     Abstract available
     
     
     
138. TAOULI B, Ba-Ssalamah A, Chapiro J, Chhatwal J, et al
     Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
     Eur Radiol. 2023;33:9167-9181.
     PubMed     Abstract available
     
     
     
139. HUANG H, Li CQ, He DN, Ruan SM, et al
     Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
     Eur Radiol. 2023;33:9336-9346.
     PubMed     Abstract available
     
     
     
140. ORCEL T, Chau HT, Turlin B, Chaigneau J, et al
     Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
     Eur Radiol. 2023;33:8999-9009.
     PubMed     Abstract available
     
     
     
141. JIN ZC, Zhong BY, Chen JJ, Zhu HD, et al
     Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
     Eur Radiol. 2023;33:8669-8681.
     PubMed     Abstract available
     
     
     
142. ZHANG K, Zhang L, Li WC, Xie SS, et al
     Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
     Eur Radiol. 2023;33:8936-8947.
     PubMed     Abstract available
     
     
     November 2023
143. DUCATEL A, Trillaud H, Reizine E, Vilgrain V, et al
     Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
     Eur Radiol. 2023 Nov 28. doi: 10.1007/s00330-023-10344.
     PubMed     Abstract available
     
     
     
144. YAN H, Xiang Z, Zhao C, Luo S, et al
     6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.
     Eur Radiol. 2023 Nov 25. doi: 10.1007/s00330-023-10346.
     PubMed     Abstract available
     
     
     
145. REN J, Lu Q, Fei X, Dong Y, et al
     Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue(R) and Sonazoid(R).
     Eur Radiol. 2023 Nov 22. doi: 10.1007/s00330-023-10371.
     PubMed     Abstract available
     
     
     
146. DEMONDION E, Ernst O, Louvet A, Robert B, et al
     Hepatic fat quantification in dual-layer computed tomography using a three-material decomposition algorithm.
     Eur Radiol. 2023 Nov 13. doi: 10.1007/s00330-023-10382.
     PubMed     Abstract available
     
     
     
147. BASTATI N, Perkonigg M, Sobotka D, Poetter-Lang S, et al
     Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
     Eur Radiol. 2023;33:7729-7743.
     PubMed     Abstract available
     
     
     
148. CANNELLA R, Santinha J, Beaufrere A, Ronot M, et al
     Performances and variability of CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: a matter of chance or standardisation?
     Eur Radiol. 2023;33:7618-7628.
     PubMed     Abstract available
     
     
     
149. CHEN X, Hu P, Yu H, Tan H, et al
     Head-to-head intra-individual comparison of total-body 2-[(18)F]FDG PET/CT and digital PET/CT in patients with malignant tumor: how sensitive could it be?
     Eur Radiol. 2023;33:7890-7898.
     PubMed     Abstract available
     
     
     
150. FERRAIOLI G
     Diffuse liver disease: the new horizon of multiparametric ultrasound.
     Eur Radiol. 2023;33:7629-7630.
     PubMed    
     
     
     
151. LEBLANC M, Kang J, Costa AF
     Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
     Eur Radiol. 2023;33:7656-7664.
     PubMed     Abstract available
     
     
     
152. PALMISANO A, Gnasso C, Cereda A, Vignale D, et al
     Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study.
     Eur Radiol. 2023;33:7756-7768.
     PubMed     Abstract available
     
     
     October 2023
153. YU H, Zhao F, Men X, Zhu H, et al
     Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
     Eur Radiol. 2023 Oct 25. doi: 10.1007/s00330-023-10268.
     PubMed     Abstract available
     
     
     
154. HWANG SH, Rhee H
     Pushing the limit of hepatocellular carcinoma diagnosis: diagnosis of subcentimetre HCC using gadoxetic acid-enhanced MRI and alpha-fetoprotein.
     Eur Radiol. 2023 Oct 23. doi: 10.1007/s00330-023-10376.
     PubMed    
     
     
     
155. JIANG H, Qin Y, Wei H, Zheng T, et al
     Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
     Eur Radiol. 2023 Oct 23. doi: 10.1007/s00330-023-10279.
     PubMed     Abstract available
     
     
     
156. ZHANG Y, Chen J, Yang C, Dai Y, et al
     Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging-based habitat imaging.
     Eur Radiol. 2023 Oct 19. doi: 10.1007/s00330-023-10339.
     PubMed     Abstract available
     
     
     
157. HEO S, Kang HJ, Choi SH, Kim S, et al
     Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M.
     Eur Radiol. 2023 Oct 18. doi: 10.1007/s00330-023-10305.
     PubMed     Abstract available
     
     
     
158. DELAGNES A, Roux M, Vilgrain V, Guiu B, et al
     Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
     Eur Radiol. 2023 Oct 11. doi: 10.1007/s00330-023-10236.
     PubMed     Abstract available
     
     
     
159. YU Q, Ungchusri E, Pillai A, Liao CY, et al
     Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
     Eur Radiol. 2023 Oct 9. doi: 10.1007/s00330-023-10203.
     PubMed     Abstract available
     
     
     
160. HUANG P, Wu F, Hou K, Zhou C, et al
     Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
     Eur Radiol. 2023 Oct 4. doi: 10.1007/s00330-023-10214.
     PubMed     Abstract available
     
     
     
161. HERNANDO D, van der Heijden RA, Reeder SB
     A better understanding of liver T1.
     Eur Radiol. 2023;33:6841-6843.
     PubMed    
     
     
     
162. HIGASHI M, Tanabe M, Yamane M, Keerthivasan MB, et al
     Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping.
     Eur Radiol. 2023;33:6844-6851.
     PubMed     Abstract available
     
     
     
163. AMORIM J
     HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend.
     Eur Radiol. 2023;33:6927-6928.
     PubMed    
     
     
     
164. WARY P, Hossu G, Ambarki K, Nickel D, et al
     Deep learning HASTE sequence compared with T2-weighted BLADE sequence for liver MRI at 3 Tesla: a qualitative and quantitative prospective study.
     Eur Radiol. 2023;33:6817-6827.
     PubMed     Abstract available
     
     
     
165. RADIYA K, Joakimsen HL, Mikalsen KO, Aahlin EK, et al
     Performance and clinical applicability of machine learning in liver computed tomography imaging: a systematic review.
     Eur Radiol. 2023;33:6689-6717.
     PubMed     Abstract available
     
     
     
166. AUER TA, Halskov S, Fehrenbach U, Nevermann NF, et al
     Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5(th) edition of the World Health Organization classification.
     Eur Radiol. 2023;33:6902-6915.
     PubMed     Abstract available
     
     
     
167. VOLPE S, Mastroleo F, Krengli M, Jereczek-Fossa BA, et al
     Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey.
     Eur Radiol. 2023;33:6736-6745.
     PubMed     Abstract available
     
     
     
168. PARK HL, Boo SH, Park SY, Moon SW, et al
     Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
     Eur Radiol. 2023;33:7274-7283.
     PubMed     Abstract available
     
     
     September 2023
169. ZAFAR S, Elbanna KY, Todd AWM, Guimaraes L, et al
     Can absolute arterial phase hyperenhancement improve sensitivity of detection of hepatocellular carcinoma in indeterminate nodules on CT?
     Eur Radiol. 2023 Sep 30. doi: 10.1007/s00330-023-10237.
     PubMed     Abstract available
     
     
     
170. XU Y, Yang Y, Ouyang J, Zhou Y, et al
     Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
     Eur Radiol. 2023 Sep 23. doi: 10.1007/s00330-023-10222.
     PubMed     Abstract available
     
     
     
171. YOON S, Shim YS, Park SH, Sung J, et al
     Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
     Eur Radiol. 2023 Sep 21. doi: 10.1007/s00330-023-10226.
     PubMed     Abstract available
     
     
     
172. DING F, Huang M, Ren P, Zhang J, et al
     Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
     Eur Radiol. 2023 Sep 11. doi: 10.1007/s00330-023-10227.
     PubMed     Abstract available
     
     
     
173. NACHIT M, Dioguardi Burgio M, Abyzov A, Garteiser P, et al
     Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
     Eur Radiol. 2023 Sep 2. doi: 10.1007/s00330-023-10131.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.